Cargando...
Recent Findings in the Regulation of Programmed Death Ligand 1 Expression
With the recent approvals for the application of monoclonal antibodies that target the well-characterized immune checkpoints, immune therapy shows great potential against both solid and hematologic tumors. The use of these therapeutic monoclonal antibodies elicits inspiring clinical results with dur...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587331/ https://ncbi.nlm.nih.gov/pubmed/31258527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01337 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|